Increased Aortic Calpain-1 Activity Mediates Age-Associated Angiotensin II Signaling of Vascular Smooth Muscle Cells
Open Access
- 21 May 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (5) , e2231
- https://doi.org/10.1371/journal.pone.0002231
Abstract
Angiotensin II (Ang II) signaling, including matrix metalloproteinase type II (MMP2) activation, has been linked to an age-associated increase in migration capacity of vascular smooth muscle cells (VSMC), and to other proinflammatory features of arterial aging. Calpain-1 activation is required for MMP2 expression in fibroblasts and is induced in cardiomyocytes by Ang II. The consequences of engagement of calpain-1 with its substrates, however, in governing the age-associated proinflammatory status within the arterial wall, remains unknown. The present findings demonstrate that transcription, translation, and activity of calpain-1 are significantly up-regulated in rat aortae or early-passage aortic VSMC from old (30-mo) rats compared to young (8-mo). Dual immunolabeling of the arterial wall indicates that colocalization of calpain-1 and Ang II increases within the aged arterial wall. To further explore the relationship of calpain-1 to Ang II, we chronically infused Ang II into young rats, and treated cultured aortic rings or VSMC with Ang II. We also constructed adenoviruses harboring calpain-1 (CANP1) or its endogenous inhibitor calpastatin (CAST) and infected these into VSMC. Ang II induces calpain-1 expression in the aortic walls in vivo and ex vivo and VSMC in vitro. The Ang II mediated, age-associated increased MMP2 activity and migration in VSMC are both blocked by calpain inhibitor 1 or CAST. Over-expression of calpain-1 in young VSMC results in cleavage of intact vimentin, and an increased migratory capacity mimicking that of old VSMC, which is blocked by the MMP inhibitor, GM6001. Calpain-1 activation is a pivotal molecular event in the age-associated arterial Ang II/MMP2 signaling cascade that is linked to cytoskeleton protein restructuring, and VSMC migration. Therefore, targeting calpain-1 has the potential to delay or reverse the arterial remodeling that underlies age-associated diseases i.e. atherosclerosis.Keywords
This publication has 57 references indexed in Scilit:
- Subcellular mobility of the calpain/calpastatin network: an organelle transientBioEssays, 2006
- Angiotensin II Activates Matrix Metalloproteinase Type II and Mimics Age-Associated Carotid Arterial Remodeling in Young RatsThe American Journal of Pathology, 2005
- Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: Role of protein kinase CCardiovascular Research, 2005
- Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cellsJournal of Molecular Medicine, 2003
- Calpain is required for MMP-2 and u-PA expression in SV40 large T-antigen-immortalized cellsBiochemical and Biophysical Research Communications, 2002
- Casein Zymography of Calpains Using a 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid–Imidazole BufferAnalytical Biochemistry, 2002
- Cell-associated activation of latent transforming growth factor-β by calpainJournal of Cellular Physiology, 1998
- Enhanced Proliferation and Migration and Altered Cytoskeletal Proteins in Early Passage Smooth Muscle Cells from Young and Old Rat Aortic ExplantsExperimental and Molecular Pathology, 1997
- Evidence for Enhanced Expression of c-fos, c-jun, and the Ca2+-Activated Neutral Protease in Rat Liver Following Carbon Tetrachloride AdministrationBiochemical and Biophysical Research Communications, 1993
- Transcriptional activation of the gene for the large subunit of human m‐calpain by 12‐o‐tetradecanoyl‐phorbol‐13‐acetateFEBS Letters, 1992